Discoveries in Targeted Therapies for Melanoma: From Molecular Mechanisms to Therapeutics
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 1 November 2024 | Viewed by 800
Special Issue Editor
Special Issue Information
Dear Colleagues,
The majority of skin cancer-related deaths is caused by malignant melanoma, a tumor originating from neural crest-derived melanocytes, and novel molecular strategies for the improved detection and treatment of melanoma are of substantial clinical significance. This Special Issue of Cancers, entitled ‘Discoveries in Targeted Therapy for Melanoma: From Molecular Mechanisms to Therapeutics’, aims at gathering original research and review papers on the current understanding of novel molecular mechanisms and therapeutic opportunities that might benefit melanoma patients in the near future.
Thank you for your research efforts. Please consider contributing to this Special Issue.
Dr. Georg Thomas Wondrak
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- malignant melanoma
- cutaneous melanoma
- uveal melanoma
- drug resistance
- targeted therapeutics
- immune checkpoint inhibitors
- targeted therapeutics
- BRAF inhibitors
- MEK inhibitors
- drug discovery
- molecular targets
- melanoma diagnostics
- precision medicine